Published in Proc Natl Acad Sci U S A on December 01, 1988
Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc Natl Acad Sci U S A (1997) 5.75
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci U S A (1988) 4.58
Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci (1999) 4.52
Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A (1990) 3.98
Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc Natl Acad Sci U S A (1996) 3.86
Transfection of Plasmodium falciparum within human red blood cells. Proc Natl Acad Sci U S A (1995) 3.70
Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A (1997) 3.61
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci U S A (1990) 3.24
Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci U S A (1997) 3.07
Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proc Natl Acad Sci U S A (1993) 3.01
Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J (1998) 2.94
A systematic map of genetic variation in Plasmodium falciparum. PLoS Pathog (2006) 2.92
Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum. Proc Natl Acad Sci U S A (1996) 2.75
A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol (1991) 2.68
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother (2003) 2.57
Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc Natl Acad Sci U S A (2009) 2.57
Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob Agents Chemother (2002) 2.52
Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc Natl Acad Sci U S A (1991) 2.49
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob Agents Chemother (2001) 2.40
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malar J (2007) 2.30
Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob Agents Chemother (2003) 2.26
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One (2009) 2.18
The evolution of drug-resistant malaria. Trans R Soc Trop Med Hyg (2008) 2.17
Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J (1992) 2.09
Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Antimicrob Agents Chemother (2010) 1.90
Insertional mutagenesis and marker rescue in a protozoan parasite: cloning of the uracil phosphoribosyltransferase locus from Toxoplasma gondii. Proc Natl Acad Sci U S A (1995) 1.79
Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations. J Infect Dis (2011) 1.68
Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Antimicrob Agents Chemother (2005) 1.63
Pyrosequencing, a high-throughput method for detecting single nucleotide polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum. J Clin Microbiol (2006) 1.61
Molecular mechanisms of drug resistance. Biochem J (1990) 1.56
Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J (2012) 1.45
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44
Drug resistance and genetic mapping in Plasmodium falciparum. Curr Genet (2008) 1.36
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal. Trop Med Int Health (2005) 1.34
Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob Agents Chemother (1998) 1.34
Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand. Antimicrob Agents Chemother (2005) 1.33
A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito. PLoS Negl Trop Dis (2010) 1.31
Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum. Antimicrob Agents Chemother (2012) 1.30
Drug resistance maps to guide intermittent preventive treatment of malaria in African infants. Parasitology (2011) 1.28
Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. Antimicrob Agents Chemother (2005) 1.24
Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin. Malar J (2011) 1.21
Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates. Malar J (2010) 1.20
Exploring the folate pathway in Plasmodium falciparum. Acta Trop (2005) 1.20
Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola. Malar J (2008) 1.20
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine. Malar J (2010) 1.19
Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand. Antimicrob Agents Chemother (2010) 1.18
Antifolate drug selection results in duplication and rearrangement of chromosome 7 in Plasmodium chabaudi. Mol Cell Biol (1989) 1.16
Quadruple mutations in dihydrofolate reductase of Plasmodium falciparum isolates from Car Nicobar Island, India. Antimicrob Agents Chemother (2006) 1.15
Targeting purine and pyrimidine metabolism in human apicomplexan parasites. Curr Drug Targets (2007) 1.14
Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar. Parasitol Res (2005) 1.11
Does the drug sensitivity of malaria parasites depend on their virulence? Malar J (2008) 1.11
Changes in the plasmodial surface anion channel reduce leupeptin uptake and can confer drug resistance in Plasmodium falciparum-infected erythrocytes. Antimicrob Agents Chemother (2008) 1.10
Unidirectional dominance of cytoplasmic inheritance in two genetic crosses of Plasmodium falciparum. Mol Cell Biol (1993) 1.09
Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother (1999) 1.09
Fitness trade-offs in the evolution of dihydrofolate reductase and drug resistance in Plasmodium falciparum. PLoS One (2011) 1.08
In vitro selection of Plasmodium falciparum drug-resistant parasite lines. J Antimicrob Chemother (2009) 1.07
Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1994) 1.07
Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum. Proc Natl Acad Sci U S A (1992) 1.07
High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana. Antimicrob Agents Chemother (2005) 1.06
A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance. J Clin Microbiol (2006) 1.04
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance. PLoS One (2010) 1.04
Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparum. Antimicrob Agents Chemother (2000) 1.04
The evolutionary landscape of antifolate resistance in Plasmodium falciparum. J Genet (2011) 1.01
High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin. Malar J (2013) 1.01
Sulfadoxine-pyrimethamine resistance in the rodent malaria parasite Plasmodium chabaudi. Antimicrob Agents Chemother (2002) 1.01
Molecular characterization of antifolates resistance-associated genes, (dhfr and dhps) in Plasmodium vivax isolates from the Middle East. Malar J (2009) 1.01
Direct evidence for the adaptive role of copy number variation on antifolate susceptibility in Plasmodium falciparum. Mol Microbiol (2013) 0.99
Multiple origins of Plasmodium falciparum dihydropteroate synthetase mutant alleles associated with sulfadoxine resistance in India. Antimicrob Agents Chemother (2011) 0.99
Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes. Proc Natl Acad Sci U S A (2011) 0.98
Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay. Antimicrob Agents Chemother (2010) 0.97
Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India. Antimicrob Agents Chemother (2009) 0.97
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children. Malar J (2011) 0.96
Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase. Antimicrob Agents Chemother (1994) 0.96
Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India. Antimicrob Agents Chemother (2012) 0.96
Application of genomics to field investigations of malaria by the international centers of excellence for malaria research. Acta Trop (2011) 0.95
Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan. Malar J (2013) 0.95
High frequency of Plasmodium falciparum CICNI/SGEAA and CVIET haplotypes without association with resistance to sulfadoxine/pyrimethamine and chloroquine combination in the Daraweesh area, in Sudan. Eur J Clin Microbiol Infect Dis (2008) 0.95
Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola. Malar J (2011) 0.95
Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana. Am J Trop Med Hyg (2012) 0.94
Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-Clindamycin. J Infect Dis (2016) 0.93
Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India. Antimicrob Agents Chemother (2009) 0.93
In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase. Antimicrob Agents Chemother (2001) 0.92
Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network. Am J Trop Med Hyg (2015) 0.91
Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic review. Malar J (2015) 0.90
Recent Progress in Functional Genomic Research in Plasmodium falciparum. Curr Genomics (2010) 0.90
Evaluation of dihydrofolate reductase and dihydropteroate synthetase genotypes that confer resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum in Haiti. Malar J (2012) 0.90
Whole genome re-sequencing identifies a mutation in an ABC transporter (mdr2) in a Plasmodium chabaudi clone with altered susceptibility to antifolate drugs. Int J Parasitol (2010) 0.90
An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand. Sci Rep (2015) 0.90
Estimation of malaria haplotype and genotype frequencies: a statistical approach to overcome the challenge associated with multiclonal infections. Malar J (2014) 0.89
Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana. Malar J (2005) 0.88
Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi. J Infect Dis (2015) 0.88
Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria. ACS Chem Biol (2009) 0.86
Tracing the origins and signatures of selection of antifolate resistance in island populations of Plasmodium falciparum. BMC Infect Dis (2010) 0.86
Monitoring antimalarial drug efficacy: current challenges. Curr Infect Dis Rep (2009) 0.86
The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics. Malar J (2007) 0.86
In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum. Malar J (2011) 0.86
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Human malaria parasites in continuous culture. Science (1976) 59.70
Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell (1984) 31.52
Separation of chromosomal DNA molecules from yeast by orthogonal-field-alternation gel electrophoresis. Nucleic Acids Res (1984) 14.43
DNA typing from single hairs. Nature (1988) 9.32
Genomic amplification with transcript sequencing. Science (1988) 7.52
Genetic analysis of the human malaria parasite Plasmodium falciparum. Science (1987) 6.48
Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc Natl Acad Sci U S A (1983) 5.46
Gene amplification in cultured animal cells. Cell (1984) 5.43
Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci U S A (1988) 4.58
Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum. Proc Natl Acad Sci U S A (1986) 3.29
Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc Natl Acad Sci U S A (1987) 2.54
A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum. Cell (1987) 2.53
Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates. Mol Pharmacol (1969) 2.46
Crystal structure of avian dihydrofolate reductase containing phenyltriazine and NADPH. J Biol Chem (1982) 2.45
Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests. Trans R Soc Trop Med Hyg (1981) 2.26
Long-range restriction maps of Plasmodium falciparum chromosomes: crossingover and size variation among geographically distant isolates. Genomics (1988) 1.65
Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum. Trans R Soc Trop Med Hyg (1984) 1.63
Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum. Antimicrob Agents Chemother (1984) 1.52
Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Cancer Res (1981) 1.49
Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei. J Biol Chem (1970) 1.48
Drug sensitivity and isoenzyme type in cloned lines of Plasmodium falciparum. Am J Trop Med Hyg (1984) 1.47
Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum. Mol Pharmacol (1987) 1.46
Effect of a single amino acid substitution on Escherichia coli dihydrofolate reductase catalysis and ligand binding. J Biol Chem (1981) 1.39
Daraprim as an antagonist of folic and folinic acids. Trans R Soc Trop Med Hyg (1952) 1.36
Comparative studies on dihydrofolate reductases from Plasmodium falciparum and Aotus trivirgatus. J Protozool (1979) 1.24
Altered dihydrofolate reductase associated with a pyrimethamine-resistant Plasmodium berghei berghei produced in a single step. Nature (1970) 1.24
Pyrimethamine resistant Plasmodium falciparum: overproduction of dihydrofolate reductase by a gene duplication. Mol Biochem Parasitol (1987) 1.23
Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi. Mol Biochem Parasitol (1984) 1.13
Cloning and characterization of mefloquine-resistant Plasmodium falciparum from Thailand. Am J Trop Med Hyg (1985) 1.11
Altered dihydrofolate reductase in pyrimethamine-resistant Plasmodium falciparum. Mol Biochem Parasitol (1986) 1.06
Chemotherapy of rodent malaria: transfer of resistance vs mutation. Exp Parasitol (1974) 0.91
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell (2000) 10.72
The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell (1995) 10.35
A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med (2001) 9.18
Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg (1995) 7.63
Genetic analysis of the human malaria parasite Plasmodium falciparum. Science (1987) 6.48
Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc Natl Acad Sci U S A (1997) 5.75
A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. Science (1999) 4.75
Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell (1997) 3.98
Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A (1990) 3.98
Frequent ectopic recombination of virulence factor genes in telomeric chromosome clusters of P. falciparum. Nature (2000) 3.90
Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc Natl Acad Sci U S A (1996) 3.86
Transfection of Plasmodium falciparum within human red blood cells. Proc Natl Acad Sci U S A (1995) 3.70
Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol (1986) 3.51
Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum. Proc Natl Acad Sci U S A (1986) 3.29
The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell (1990) 3.12
Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. J Clin Invest (1990) 3.04
High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J Infect Dis (2001) 2.78
Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol Biochem Parasitol (1994) 2.67
Malaria. Cooperative silencing elements in var genes. Nature (2001) 2.62
Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol (2000) 2.62
Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. Genomics (1996) 2.58
A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum. Cell (1987) 2.53
Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase. Mol Pharmacol (1998) 2.50
Homologous recombination within subtelomeric repeat sequences generates chromosome size polymorphisms in P. falciparum. Cell (1988) 2.46
Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology (1987) 2.45
Cross-species interactions between malaria parasites in humans. Science (2000) 2.43
Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol Mol Biol Rev (1997) 2.42
Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans R Soc Trop Med Hyg (2001) 2.34
Genetic diversity and dynamics of plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology (2000) 2.10
Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood (2000) 2.10
Antigenic diversity in the human malaria parasite Plasmodium falciparum. Science (1982) 2.09
Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00
Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis (2001) 1.94
Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans R Soc Trop Med Hyg (1998) 1.91
Genetic structure and dynamics of Plasmodium falciparum infections in the Kilombero region of Tanzania. Trans R Soc Trop Med Hyg (1999) 1.79
Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am J Trop Med Hyg (1998) 1.75
Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi--a rodent malaria model. Parasite Immunol (1990) 1.74
Random mating in a natural population of the malaria parasite Plasmodium falciparum. Parasitology (1994) 1.73
Molecular karyotype of Plasmodium falciparum: conserved linkage groups and expendable histidine-rich protein genes. Proc Natl Acad Sci U S A (1987) 1.72
Enzyme typing of Plasmodium falciparum from African and some other Old World countries. Trans R Soc Trop Med Hyg (1981) 1.72
Genetic studies on Plasmodium chabaudi: recombination between enzyme markers. Parasitology (1975) 1.69
Isolation of multiple sequences from the Plasmodium falciparum genome that encode conserved domains homologous to those in erythrocyte-binding proteins. Proc Natl Acad Sci U S A (1995) 1.69
Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol Cell Biol (1991) 1.68
An RFLP map of the Plasmodium falciparum genome, recombination rates and favored linkage groups in a genetic cross. Mol Biochem Parasitol (1992) 1.68
Long-range restriction maps of Plasmodium falciparum chromosomes: crossingover and size variation among geographically distant isolates. Genomics (1988) 1.65
Population structure of Plasmodium falciparum in villages with different malaria endemicity in east Africa. Am J Trop Med Hyg (1997) 1.65
Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum. Trans R Soc Trop Med Hyg (1984) 1.63
Characterisation of a repetitive DNA sequence from the malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol (1986) 1.61
Genetic diversity in Plasmodium falciparum. Adv Parasitol (1990) 1.58
Estimation of inbreeding coefficients from genotypic data on multiple alleles, and application to estimation of clonality in malaria parasites. Genet Res (1995) 1.55
The human genes for GM-CSF and IL 3 are closely linked in tandem on chromosome 5. Blood (1988) 1.54
Plasmodium falciparum: parasite typing by using a multicopy microsatellite marker, PfRRM. Exp Parasitol (1998) 1.52
Host sequences in Plasmodium falciparum and Plasmodium vivax genomic DNA: horizontal transfer or contamination artifact? FEBS Lett (2001) 1.49
Diversity of Plasmodium falciparum clones infecting children living in a holoendemic area in north-eastern Tanzania. Acta Trop (2002) 1.49
Detection of low level Plasmodium falciparum gametocytes using reverse transcriptase polymerase chain reaction. Mol Biochem Parasitol (1999) 1.48
Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum. Parasitology (1993) 1.47
New observations on the malaria parasites of rodents of the Central African Republic - Plasmodium vinckei petteri subsp. nov. and Plasmodium chabaudi Landau, 1965. Ann Trop Med Parasitol (1975) 1.47
Age- and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea. Parasitology (2000) 1.46
Polymorphism of the TRAP gene of Plasmodium falciparum. Proc Biol Sci (1990) 1.45
A genetic investigation of virulence in a rodent malaria parasite. Parasitology (1976) 1.45
Mixed-genotype infections of malaria parasites: within-host dynamics and transmission success of competing clones. Proc Biol Sci (1997) 1.45
Genetic diversity of Plasmodium falciparum in a village in eastern Sudan. 1. Diversity of enzymes, 2D-PAGE proteins and antigens. Trans R Soc Trop Med Hyg (1992) 1.45
Current views on the population structure of plasmodium falciparum: Implications for control. Parasitol Today (1997) 1.44
Mixed-genotype infections of the rodent malaria Plasmodium chabaudi are more infectious to mosquitoes than single-genotype infections. Parasitology (1997) 1.44
Sudden increase in virulence in a strain of Plasmodium berghei yoelii. Ann Trop Med Parasitol (1975) 1.41
Genetic recombination in Plasmodium berghei. Parasitology (1973) 1.40
Protein variation in clones of Plasmodium falciparum detected by two dimensional electrophoresis. Mol Biochem Parasitol (1985) 1.38
Membrane modifications in erythrocytes parasitized by Plasmodium falciparum. Mol Biochem Parasitol (1997) 1.33
EBL-1, a putative erythrocyte binding protein of Plasmodium falciparum, maps within a favored linkage group in two genetic crosses. Mol Biochem Parasitol (2000) 1.31
Restriction polymorphisms and fingerprint patterns from an interspersed repetitive element of Plasmodium falciparum DNA. Mol Biochem Parasitol (1993) 1.31
Reduced extension temperatures required for PCR amplification of extremely A+T-rich DNA. Nucleic Acids Res (1996) 1.30
The Giardia lamblia trophozoite contains sets of closely related chromosomes. Nucleic Acids Res (1988) 1.29
Plasmodium falciparum: isolation of large numbers of parasite clones from infected blood samples. Exp Parasitol (1996) 1.25
Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum. Mol Biochem Parasitol (2000) 1.25
Interchromosomal exchange of a large subtelomeric segment in a Plasmodium falciparum cross. EMBO J (1994) 1.25
Purification and partial characterization of an unusual protein of Plasmodium falciparum: histidine-rich protein II. Mol Biochem Parasitol (1989) 1.23
Telomeric location of Giardia rDNA genes. Mol Cell Biol (1991) 1.22
Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect Immun (1998) 1.22
Intra-cluster recombination and var transcription switches in the antigenic variation of Plasmodium falciparum. Mol Biochem Parasitol (1999) 1.21
Persistence of drug-resistant malaria parasites. Lancet (1978) 1.21
Of mice and malaria mutants: unravelling the genetics of drug resistance using rodent malaria models. Trends Parasitol (2001) 1.21
Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages. J Exp Med (1988) 1.21
Proof of intragenic recombination in Plasmodium falciparum. Mol Biochem Parasitol (1994) 1.20
Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem Pharmacol (1992) 1.19
Genetic hybrids of Plasmodium falciparum identified by amplification of genomic DNA from single oocysts. Mol Biochem Parasitol (1991) 1.19
Gene synteny in species of Plasmodium. Mol Biochem Parasitol (1998) 1.18
Genetic diversity of Plasmodium falciparum shows geographical variation. Am J Trop Med Hyg (1990) 1.18
A chloroquine resistance locus in the rodent malaria parasite Plasmodium chabaudi. Mol Biochem Parasitol (1998) 1.16
Towards a high-resolution map of the Plasmodium falciparum genome. Parasitol Today (1992) 1.16
Antigenic diversity in Plasmodium falciparum. Prog Allergy (1988) 1.16
Electron microscopy of fibers and discs of hemoglobin S having sixfold symmetry. Proc Natl Acad Sci U S A (1977) 1.16
Mature liver stages of cloned Plasmodium falciparum share epitopes with proteins from sporozoites and asexual blood stages. Parasite Immunol (1988) 1.14
Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am J Trop Med Hyg (1996) 1.14
On the biological and biochemical nature of cloned populations of Strongyloides ratti. J Helminthol (1992) 1.13
Crystallization of deoxyhemoglobin S by fiber alignment and fusion. J Mol Biol (1979) 1.13
Expressed var genes are found in Plasmodium falciparum subtelomeric regions. Mol Cell Biol (1997) 1.11
Commitment to sexual differentiation in the human malaria parasite, Plasmodium falciparum. Parasitology (2000) 1.11
Use of antimalarial drugs in Mali: policy versus reality. Am J Trop Med Hyg (1998) 1.10